Search Results - "Hedge, Shweta"
-
1
291 Dual-specific antibodies blocking both PD-L1 and PD-L2 engagement of PD-1 restore anti-tumor immunity
Published in Journal for immunotherapy of cancer (01-11-2021)Get full text
Journal Article -
2
Abstract 5745: Proposing the best MET inhibitor to improve anti-PD-1 efficacy in HCC
Published in Cancer research (Chicago, Ill.) (04-04-2023)“…Despite recently approved immunotherapy combinations, Hepatocellular carcinoma (HCC) remains among the most therapeutically intractable cancers with a 5-year…”
Get full text
Journal Article -
3
Abstract 4213: Targeting the cMet inhibitors combined with anti-PD-1 therapy: Preclinical approach to turn the resistance into opportunities for overcoming tumor evasion
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Liver cancer is the fourth most common cause of cancer-related mortality world-wide, and Hepatocellular carcinoma (HCC) is the most common form of liver cancer…”
Get full text
Journal Article -
4
P-159 Adiponectin Administration Reduces the Severity of Intestinal Inflammation and Cancer
Published in Inflammatory bowel diseases (01-12-2014)Get full text
Journal Article -
5
Effects of Adiponectin on DSS-induced Acute Ulcerative Colitis in Mice: P-182 YI
Published in Inflammatory bowel diseases (01-12-2012)Get full text
Journal Article -
6